Receptor activator of nuclear factor-κB ligand and osteoprotegerin: maintaining the balance to prevent bone loss

Ítems similars

• Role of Osteoprotegerin and Receptor Activator of Nuclear Factor-κB Ligand in Bone Loss Related to Advanced Chronic Obstructive Pulmonary Disease
  per: Ugay, Ludmila, et al.
  Publicat: (2016)
• Receptor Activator of Nuclear Factor κB Ligand and Osteoprotegerin Regulation of Bone Remodeling in Health and Disease
  per: Kearns, Ann E., et al.
  Publicat: (2008)
• Does Osteoprotegerin or Receptor Activator of Nuclear Factor-κB Ligand Mediate the Association between Bone and Coronary Artery Calcification?
  per: Bakhireva, Ludmila N., et al.
  Publicat: (2008)
• Receptor Activator of Nuclear Factor κB Ligand (RANKL)/Osteoprotegerin (OPG) Ratio Is Increased in Severe Osteolysis
  per: Grimaud, Eva, et al.
  Publicat: (2003)
• The Role of the Receptor Activator of Nuclear Factor-κB Ligand/Osteoprotegerin Cytokine System in Primary Hyperparathyroidism
  per: Nakchbandi, Inaam A., et al.
  Publicat: (2008)